CytoPharm Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Cytopharm Inc Announces Appointment of CEO
Cytopharm Inc announced that it has appointed Zeng Minghuang as Chief Executive Officer (CEO) of the Company, effective July 31, 2013.
Latest Key Developments in Food
- La Doria SpA proposes FY 2013 dividend; issues FY 2014 outlook in-line with estimates
- General Mills Inc reaffirms FY 2014 EPS outlook; gives Q3 2014 EPS outlook below analysts' estimates; gives Q4 2014 EPS outlook
- Sunjuice Holdings announces FY 2013 dividend payment
- Kee Song Bio-Technology Holdings announces FY 2013 dividend payment
- Share this
- Digg this